Renal Transplant Registry Report 2008
|
|
- Henry O’Connor’
- 5 years ago
- Views:
Transcription
1 Renal Transplant Registry Report 28 Contents:. Introduction Page 2. Summary of transplant activity Page 2 3. Graft and Patient Survival analysis Page 3 4. Acute rejection Page 24. Comparison of graft and patient outcomes between European Renal Association (ERA) countries and the Republic of Ireland Page 27
2 . Introduction This document summarises the outcome of kidney Transplantation in Ireland as it stands at the end of 28. This work is the result of the transplant activity at Beaumont Hospital and the combined care by all the renal teams across the country. Highlights of this report include; Increasing age of Transplant recipients from a median of 4 years in 2 to 47 years in 28. Progressive increase in waiting time from 6 months in 2 to 8 months in 28 Progressive decline in cold ischemic time from a mean of 2 hours in 2 to hours in 28 The expansion of LRD transplantation over the last 3 years The progressive improvement in year adult cadaveric graft survival from 87% in period to 96% in The progressive improvement in year adult cadaveric graft survival from 7% in to 77% in Excellent long term outcome of kidney pancreas transplantation Progressive decline in acute rejection post transplantation from 33% in 993 to 6.8% in 28 Results are comparable to and better to most European countries. Current kidney Transplantation is failing to meet the demand. The production of this analysis is critically dependent on centres continuing to provide long term follow up data to the Renal Transplant Registry Prof Peter J Conlon FRCPI, Consultant Nephrologist/Renal Transplant Physician Mr Patrick O Kelly MSc Renal Unit Statistician Mr David Hickey FRCSI, Consultant Transplant Surgeon
3 2. Summary of transplant activity Table.: Summary of transplant activity Category Transplanted 27 Transplanted 28 Difference +/- in 28 Total number of transplanted kidneys Number of Cadaveric kidneys Number of Living + donor kidneys Number of Simultaneous Pancreas/Kidney Number of 2-2 Combined Kidney/Liver Percentage of male 9 9 transplant recipients Percentage of 2nd or subsequent transplants Table.2: Recipient age at transplant years 2-28 Year Median age Age range
4 Figure.: Median recipient age at transplant years 2-28 Median age at transplant Table.3: Referring centre of transplant recipients Centre Number 27 % 27 Number 28 % 28 Numbers +/- in 28 BCH..7 BEAUMONT CAVAN CORK GALWAY LETTERKENNY LIMERICK MATER OLH CRUMLIN ST. JAMES.7. - SLIGO ST. VINCENTS TALLAGHT TEMPLE STREET TULLAMORE UK WATERFORD
5 Figure.2: Mode renal replacement prior to transplantation 28 8% 28% 64% Peritoneal dialysis = 28% Haemodialysis = 64% Pre-emptive = 8% Figure.3: Cause of end stage renal disease for 28 transplant recipients 7% 3% % 3% 2% 9% 2% 7% 7% 9% APKD = % Congenital = 3% Pylonephritis = 2% Diabetes 7% Glomeronephritis = 9% Hypertension = 7% Interstitial Nephritis = 2% Miscellaneous 9% Not Known = 7% Renal Vascular = 3% 4
6 Table.4: Time on dialysis and time on waiting list pool 2-28 Year Median time on dialysis (months) IQR time on dialysis (months) Median time on pool (months) IQR time on pool (months) Figure.4: Time on dialysis and time on waiting list pool 2-28 Months Median time on waiting list Median time on dialysis
7 Table.: Serum creatinine post transplant 2 28 Year Median Creatinine month Post tx. Post tx. Median Creatinine 3months Figure.: Serum creatinine post transplant 2 28 Median Creatinine year Post tx. Serum Creatinine (mmol/l) Median Creatinine month post Tx Median Creatinine year post Tx Median Creatinine 3 months post Tx 6
8 Table.6: Cold Ischaemic Time (CIT) 2 28 Year Mean CIT SD CIT Figure.6: Cold Ischaemic Time (CIT) 2 28 CIT (hours) Year 7
9 Table.7: Delayed graft function post transplant (defined as the need for dialysis) 2 28 Year Number DGF (%) 2 (7.9) 2 7 (3.7) (.9) 23 2 (.7) 24 2 (4.2) 2 8 (4.) 26 2 (4.) 27 8 (2.3) 28 2 (7.2) Figure.7: Delayed graft function post transplant 2 28 % Delayed Graft Function
10 Table.8: Donor cause of death 2 28 Year Number Trauma (%) Number Non Trauma (%) 2 4 (43) 73 (7) 2 46 (38) 76 (62) 22 6 (42) 82 (8) 23 (4) 79 (9) (3) 68 (47) 2 63 () 64 () (3) 92 (6) 27 2 (37) 89 (63) (32) 93 (68) Figure.8: Donor cause of death % donor cause of death Trauma Non Trauma Table.9: Donor age 2 28 Year Median donor age Inter-quartile range 2 39 [2-47] 2 3 [22-47] [2-46] [2-47] 24 3 [24-48] 2 42 [2 - ] [26-3] 27 4 [27-3] [28-4] 9
11 Figure.9: Donor age 2 28 Median donor age Table.: Donor gender 2 28 Year Number Male donors (%) Number Female donors (%) 2 8 (64) 4 (36) 2 6 () 6 () (67) 46 (33) (6) 2 (39) (7) 62 (43) 2 7 (6) 6 (44) () 69 (49) () 62 (4) (6) 6 (44) Figure.: Donor gender % donor gender Male Female
12 Table.: Tacrolimus levels post transplant Table.2: Mean HLA miss matches 2 28 year Mean hla (std. dev.) Number miss matches (% of total) Number 222 miss matches (% of total) (.29) 3.3 (.3) 2.7 (.38) 3. (.44) 3. (.47) 3. (.37) 3. (.4) 3.2 (.9) 3. (.49) 6 (4.7) 2 (.6) (6.9) 8 (6.) 9 (6.) (3.9) 2 (8.3) 2 (8.2) 9 (6.2) 4 (3.) (4.) (.7) (3.7) (3.4) 6 (4.6) 7 (4.8) 6 (4.) (3.4) Total 3. (.44) 73 (.9) 44 (3.) Table.: Mean HLA miss matches 2 28 Mean HLAMM Year
13 Table.3: Living related donor transplants (LRD) 2 28 Year transplanted Frequency Percent of total transplants Mean age of LRD recipient (Std. Dev.) (7.8) 43. (4.8) (.) 2.7 (.6) 2.8 (7.) 34. (22.) 32.6 (2.7) Total (7.) Figure.2: Number of LRD transplants Number of living related transplants
14 3. Graft and Patient Survival analysis Adult cadaveric graft outcome Table 2.: Overall median adult cadaveric graft survival No of patients Median graft survival (years) [9% C.I.] [.6 2.] Table 2.2: Estimated adult cadaveric graft survival Follow up time (years) Estimated graft survival [9% C.I.] [ [73.6. [ [34.92 Figure 2.: Kaplan-Meier adult cadaveric graft survival estimates 7 % survival Time (years) 3
15 Table 2.3: Cox proportional Hazards graft survival model for adult cadaveric kidneys Variables HR [9% conf. int] P value Recipient age.6 [. -.22] <. Donor age. [. -.2] <. Recipient sex.4 [.9 -.2].9 Transplant number.4 [.2 -.9]. Donor sex.894 [ ].9 CIT. [ ].388 HLA miss matches.98 [ ].466 Delayed graft function.24 [.2 -.].38 Acute rejection (3 month).282 [ ]. Era transplanted*.828 [ ]. Tachrolimus.92 [ ].3 MMF.32 [ ].867 * Eras used = , , , Table 2.4: Logistic regression model to test for effect on delayed graft function for adult cadaveric kidneys Variables Odds ratio [9% conf. int] P value Recipient age Donor age Recipient sex Donor sex Era transplanted CIT Transplant number HLA miss matches.7 [ ].38 [.27 -.].6 [ ].33 [ ].497 [ ].62 [ ].996 [ ].97 [ ].23 < <. <
16 Paediatric cadaveric Graft outcome Table 2.: Overall median paediatric cadaveric graft survival No of patients Median graft survival (years) [9% C.I.] 88.9 [ ] Table 2.6: Estimated paediatric cadaveric graft survival Follow up time (years) Estimated graft survival [9% C.I.] 8.8 [ ] 7.4 [ ].86 [ ] [ ] Figure 2.2: Kaplan-Meier paediatric cadaveric graft survival estimates 7 % survival Time (years)
17 Simultaneous Pancreas Kidney (SPK) Graft outcome Table 2.7: Overall medianspk cadaveric graft survival No of patients Median graft survival (years) [9% C.I.] 94.6 [ 8.9 not defined] Table 2.8: Estimated SPK cadaveric graft survival Follow up time (years) Estimated graft survival [9% C.I.] 94.6 [ ] 83.2 [ ] 6.38 [ ] [ ] Figure 2.3: Kaplan-Meier SPK cadaveric graft survival estimates % survival Time (years) 6
18 Graft survival adult cadaveric st, 2 nd, 3 rd Table 2.9: overall median graft survival for cadaveric adult st, 2 nd & 3 rd Transplant number No of patients Median graft survival (years) [9% C.I.],9.4 [.6 2.2] [.2 3.7] 3 7. [ 4.7.3] grafts Table 2.:Estimated cadaveric adult st,2 nd & 3 rd graft survival Transplant number Follow up time Estimated graft survival [9% C.I.] (years) [ ] 7.29 [ ].9 [ ] [ ] [ ] [ ] 8.3 [ ] [ ] 88. [ ] 63.2 [ ] [ ] [ ] Figure 2.4: Kaplan-Meier cadaveric adult st, 2 nd & 3 rd graft survival estimates 7 % survival Time (years) First transplant Third transplant Second transplant 7
19 Graft survival adult cadaveric by four time periods transplanted Table 2.: adult cadaveric graft survival by era transplanted at,, & years Follow up time (years) Period transplanted Estimated graft survival [9% C.I.] [ ] 68.8 [ ] 47.4 [ ] [ ] Figure 2.: adult cadaveric graft survival by era transplanted [ ] 7.66 [ ] 3.3 [ ] 89.3 [ ] 77.8 [ ] 96.3 [ ] 7 % survival Time (years)
20 Graft survival paediatric cadaveric by era Table 2.2: Paediatric cadaveric graft survival by era transplanted at,,& years Follow up time (years) Period transplanted Eestimated graft survival [9% C.I.] [ ] 6.36 [ ] [ ] [ ] [ ] [ ] 8.8 [ ] [ ] [ ] [ ] Figure 2.6: Paediatric cadaveric graft survival by era transplanted at,,& years 7 % survival Time (years)
21 Patient survival adult cadaveric (From time of first graft) Table 2.3: Estimated adult cadaveric patient survival at,,& years Follow up time (years) Estimated patient survival [9% C.I.] 9.8 [ ] 87.6 [ ] 7.2 [ ] 6.9 [ ] Table 2.4: Cox proportional Hazards patient survival model for adult cadaveric transplants Variables HR [9% conf. int] P value Recipient age Donor age Recipient sex Donor sex CIT HLA miss matches Delayed graft function Acute rejection (3 month) Era transplanted Tachrolimus MMF.6 [ ]. [.4 -.8].4 [ ].4 [ ].894 [ ]. [ ].98 [ ].24 [ ].282 [ ].828 [ ].92 [ ] < Figure 2.7: Kaplan-Meier adult cadaveric patient survival estimates 7 % survival Time (years) 2
22 Patient survival paediatric cadaveric Table 2.: Estimated paediatric cadaveric patient survival at,,& years Follow up time (years) Estimated patient survival [9% C.I.] 96.9 [ ] 94. [ ] 9.82 [ ] [ ] Figure 2.8: Kaplan-Meier paediatric cadaveric patient survival estimates 7 % survival Time (years) 2
23 Patient survival SPK Table 2.6: Estimated SPK patient survival at,,& years Follow up time (years) Estimated patient survival [9% C.I.] 9.3 [ ] [ ] 74.6 [ ] 49.6 [ ] Figure 2.9: Kaplan-Meier SPK patient survival estimates 7 % survival Time (years) 22
24 Patient survival adult cadaveric by era Table 2.7: Adult cadaveric patient survival by era transplanted at,, & years Follow up time (years) Period transplanted Estimated patient survival [9% C.I.] [ ] 83. [ ] 68. [ ] 6.44 [ ] [ ] 86.7 [ ] [ ] 9.37 [ ] 88. [ ] 98.2 [ ] Figure 2.: Adult cadaveric patient survival by era transplanted at,, & years 7 % survival Time (years)
25 4. Acute rejection Acute rejection is defined as either a biopsy proven Type or Type 2 acute cellular rejection, vascular rejection and/or the need for an empirical treatment for acute rejection within the first 3 months of transplantation. Table 3.: Acute rejection rate by year era transplanted ERA Number transplanted Number of acute rejection patients % acute rejection Figure 3.: Percent acute rejection by era transplanted % acute rejection Table 3.2: Acute rejection rate by year transplanted 2 28 Year Number Number of acute % acute rejection transplanted rejection patients
26 Figure 3.2: Acute rejection rate by year transplanted %acute rejection Table 3.3: Acute rejection by intention to treat therapy adult patients Immunosuppressant Number transplanted Number of acute rejection % acute rejection CYA DC CYA DC A CYA DC A / ATG CYA MMF DC CYA RAP DC FK DC A FK DC A / ATG FK MMF DC FK MMF DC / ATG FK MMF DC / SIM patients Figure 3.3: Acute rejection by intention to treat therapy adult patients CYA DC CYA DC A CYA DC A / ATG CYA MMF DC CYA RAP DC FK DC A FK DC A / ATG FK MMF DC FK MMF DC / ATG FK MMF DC / SIM % acute rejection 2
27 Table 3.4: Acute rejection by intention to treat therapy paediatric patients Immunosuppressant Number transplanted Number of acute rejection % acute rejection CYA DC CYA DC A CYA DC A / ATG FK DC A FK DC A / ATG FK MMF DC FK MMF DC / ATG FK MMF DC / SIM patients Figure 3.4: Acute rejection by intention to treat therapy paediatric patients CYA DC CYA DC A CYA DC A / ATG FK DC A FK DC A / ATG FK MMF DC FK MMF DC / ATG FK MMF DC / SIM % acute rejection 26
28 . Comparison of graft and patient outcomes between European Renal Association (ERA) countries and the Republic of Ireland Introduction The ERA Registry collects data on renal replacement therapy (RRT) via the national and regional renal registries in Europe. For this section comparisons are made between 6 ERA countries and the Republic of Ireland which is not affiliated to ERA. Data was gleaned from the 27 ERA report (updated in June 29). There are 9 regions of Spain with separate results. Included in this report are the 3 largest regions by population, Andalusia, Catalonia and Valencia. The countries are listed in tables 4. and 4.2. Statistical analysis Unadjusted survival probabilities were calculated using the Kaplan-Meier method. In this section, patient survival after the first transplant, and graft survival after the first transplant are presented in tables and graphs by age, gender and cause of renal failure. Survival probabilities are presented as percentages from to. For the analysis of survival data two five-year cohorts were used: , one and five-year survival probabilities. 2-2, one- and two-year survival probabilities. For patient survival from first graft, event is defined as death of patient. Censoring is at loss to follow-up and end of follow-up time. For graft survival from first graft, event is defined as death of patient or graft loss. Censoring is at loss to follow-up and end of follow-up time. 27
29 Table 4.: Rates of transplantation per million populations for ERA countries and the Republic of Ireland for the year 27 Country Deceased Living Unknown Total donors Donors Source Austria Belgium Denmark Finland Greece Iceland Italy Norway Romania Spain, Andalusia Spain, Catalonia Spain, Valencia region Sweden Netherlands England Northern Ireland Scotland Wales Republic of Ireland Figure 4.: Total rates of transplantation per million populations for ERA countries and the Republic of Ireland for the year 27 Renal transplants per million population Romania Italy Greece Iceland NorthernIreland Denmark Finland Republic of Ireland Scotland Wales England Belgium Sweden Spain, Andalusia Spain, Valencia Austria Netherlands Norway Spain, Catalonia 28
30 Table 4.2: Percentages of renal replacement therapy for ERA group of countries and the Republic of Ireland Country % Transplant % HD % PD % Other Austria Belgium Denmark Finland Greece Iceland Italy Norway Romania Spain, Andalusia Spain, Catalonia Spain, Valencia region Sweden Netherlands England Northern Ireland Scotland Wales Republic of Ireland Figure 4.2: Percentages of renal replacement therapy with a functioning transplant for ERA group of countries and the Republic of Ireland Prevalent % on RRT with functioning transplant Romania Greece Italy Wales Spain, Valencia Belgium Denmark England NorthernIreland Spain, Andalusia Scotland Austria Spain, Catalonia Republic of Ireland Sweden Netherlands Finland Iceland Norway 29
31 Table 4.3: Patient survival from first cadaveric transplant Group Rep. of Ireland One year Survival in % ERA countries One year Survival in % (9% CI) (9% CI) (9% CI) ( ) 97.7 ( ) 93. ( ) 92.9 ( ) 97.9 ( ) 97.8 ( ) 94.9 ( ) 89. ( ) Rep. of Ireland Five year Survival in % 93. ( ) 9.9 ( ) 83.6 ( ) 64.3 ( ) ERA countries Five year Survival in % (9% CI) 9.2 ( ) 93. ( ) 84. ( ) 69.6 ( ) Men Women 94. ( ) 96. ( ) 9.4 ( ) 96. ( ) 86.4 ( ) 9.9 ( ) 86.3 ( ) 87.2 ( ) Diabetes Hypertension Glomerulonephritis Othercause 9. ( ) 94. ( ) 96.8 ( ) 94.9 ( ) 94. ( ) 93.3 ( ) 96.7 ( ) 9.9 ( ). ( ) 74. (9.-84.) 94.3 ( ) 9. ( ) 8.8 ( ) 8.9 ( ) 89.4 ( ) 87.6 ( ) All 9. ( ) 9.6 ( ) 88.2 (8.-9.7) 86.6 ( ) Figure 4.3: One-year Patient survival from first cadaveric transplant % survival years 2-44 years 4-64 years 6+ years Men Women Diabetes Hypertension Glomerulonephritis Othercause ESRD All Republic of Ireland ERA counries 3
32 Figure 4.4: Five-year Patient survival from first cadaveric transplant % survival years 2-44 years 4-64 years 6+ years Men Women Diabetes Hypertension Glomerulonephritis Othercause ESRD All Republic of Ireland ERA countries Table 4.4: Patient survival from first cadaveric transplant 2 2 Group Rep. of Ireland One year Survival in % ERA countries One year Survival in % (9% CI) (9% CI) (9% CI) (9.-99.) 9.9 ( ) 9.4 ( ) 98. ( ) 98.2 ( ) 9. (94.-9.) 88.7 (87.-9.) Rep. of Ireland Two year Survival in % 97. ( ) 94. ( ) 86. ( ) ERA countries Two year Survival in % (9% CI) 97. ( ) 97.4 ( ) 92. ( ) 84.7 ( ) Men Women 97. ( ) 9.4 ( ) 9.4 ( ) 96. ( ) 96. ( ) 93.9 ( ) 93. ( ) 94. ( ) Diabetes Hypertension Glomerulonephritis Othercause 86.7 ( ) 94. ( ) 98.4 ( ) 97.4 ( ) 93. ( ) 93. ( ) 96.7 ( ) 96.2 ( ) 83.3 ( ) 86.3 ( ) 98.4 ( ) 96. ( ) 9.6 ( ) 9. ( ) 9.6 ( ) 94.3 ( ) All 96.7 ( ) 9.6 ( ) 9.2 ( ) 93.7 ( ) 3
33 Figure 4.6: One-year Patient survival from first cadaveric transplant % survival years 2-44 years 4-64 years 6+ years Men Women Diabetes Hypertension Glomerulonephritis Othercause ESRD All Republic of Ireland ERA countries Figure 4.7: Two-year Patient survival from first cadaveric transplant % survival years 2-44 years 4-64 years 6+ years Men Women Diabetes Hypertension Glomerulonephritis Othercause ESRD All Republic of Ireland ERA countries 32
34 Table 4.: Graft survival from first cadaveric transplant Group Rep. of Ireland One year Survival in % (9% CI) ERA countries One year Survival in % (9% CI) -9 years 2-44 years 4-64 years 6+ years 87. ( ) 92.2 ( ) 84. ( ) 83.3 ( ) 89.9 ( ) 9. ( ) 89.8 (89.-9.) 84. ( ) Rep. of Ireland Five year Survival in % (9% CI) 7.7 ( ) 8.2 ( ) 74. ( ) 7. ( ) ERA countries Five year Survival in % (9% CI) 78.9 ( ) 8.6 ( ) 76. ( ) 64.3 ( ) Men Women 87.4 ( ) 88.4 ( ) 9.3 ( ) 89. ( ) 7. ( ) 76.3 ( ) 77.4 ( ) 77.7 ( ) Diabetes Hypertension Glomerulonephritis Other cause 8. ( ) 9. ( ) 88.6 (8.-93.) 87.3 (83.-9.) 9.4 ( ) 86.6 ( ) 9. (9.-92.) 9. ( ). ( ) 68. ( ) 78.9 (7.-8.) 77. ( ) 7.7 ( ) 72. (7.-74.) 78.7 ( ) 78.4 ( ) All 87.8 ( ) 9. (89.-9.) 7. ( ) 77. ( ) Figure 4.8: One-year Graft survival from first cadaveric transplant % survival years 2-44 years 4-64 years 6+ years Men Women Diabetes Hypertension Glomerulonephritis Othercause ESRD All Republic of Ireland ERA countries 33
35 Figure 4.9: Five-year Graft survival from first cadaveric transplant % survival years 2-44 years 4-64 years 6+ years Men Women Diabetes Hypertension Glomerulonephritis Othercause ESRD All Republic of Ireland ERA countries Table 4.6: Graft survival from first cadaveric transplant 2 2 Group Rep. of Ireland One year Survival in % (9% CI) ERA countries One year Survival in % (9% CI) -9 years 2-44 years 4-64 years 6+ years 97.9 ( ) 96. ( ) 9.2 ( ) 88. ( ) 9.2 ( ) 92. ( ) 89.7 ( ) 82.2 ( ) Rep. of Ireland Two year Survival in % (9% CI) 9.7 ( ) 9.6 ( ) 89.4 ( ) 82.7 ( ) ERA countries Two year Survival in % (9% CI) 89. ( ) 9. ( ) 86.6 ( ) 77. ( ) Men Women 94.4 ( ) 9.8 ( ) 89.9 ( ) 9. ( ) 92.6 ( ) 9.3 ( ) 87. ( ) 87.2 ( ) Diabetes Hypertension Glomerulonephritis Othercause 8. (6.8-9.) 92.2 ( ) 96.9 ( ) 93.6 ( ) 89.6 ( ) 87. ( ) 9. (9.-9.9) 9. ( ) 8. (6.8-9.) 84.3 (7.-9.8) 96. ( ) 92.3 ( ) 86. ( ) 82.6 ( ) 88.6 ( ) 87.4 ( ) All 93. ( ) 9. ( ) 9.7 ( ) 87. ( ) 34
36 Figure 4.: One-year Graft survival from first cadaveric transplant % survival years 2-44 years 4-64 years 6+ years Men Women Diabetes Hypertension Glomerulonephritis Othercause ESRD All Republic of Ireland ERA countries Figure 4.: Two-year Graft survival from first cadaveric transplant % survival years 2-44 years 4-64 years 6+ years Men Women Diabetes Hypertension Glomerulonephritis Othercause ESRD All Republic of Ireland ERA countries 3
Few things in medicine have such profound effects on so many as transplantation.
Annual Report 2015 Few things in medicine have such profound effects on so many as transplantation. Lorraine Hayes kidney Transplant Recipient beaumont.ie 1 Lorraine Hayes Kidney Transplant Recipient
More information. Time to transplant listing is dependent on. . In 2003, 9.1% of all prevalent transplant. . Patients with diabetes mellitus are less
Chapter 5: Joint Analyses with UK Transplant in England and Wales; Access to the Renal Transplant Waiting List, Time to Listing, Diabetic Access to Transplantation and the Influence of Social Deprivation
More informationSocial deprivation, ethnicity and access to kidney transplantation in England and Wales. Udaya Udayaraj
Social deprivation, ethnicity and access to kidney transplantation in England and Wales Udaya Udayaraj Introduction (1) Kidney transplantation Improved survival compared to remaining on dialysis Better
More informationReduced graft function (with or without dialysis) vs immediate graft function a comparison of long-term renal allograft survival
Nephrol Dial Transplant (2006) 21: 2270 2274 doi:10.1093/ndt/gfl103 Advance Access publication 22 May 2006 Original Article Reduced graft function (with or without dialysis) vs immediate graft function
More informationBK virus infection in renal transplant recipients: single centre experience. Dr Wong Lok Yan Ivy
BK virus infection in renal transplant recipients: single centre experience Dr Wong Lok Yan Ivy Background BK virus nephropathy (BKVN) has emerged as an important cause of renal graft dysfunction in recent
More informationERA-EDTA Registry Annual Report 2001
ERA-EDTA Registry Annual Report 2001 Suggested citation ERA-EDTA Registry: ERA-EDTA Registry 2001 Annual Report. Academic Medical Center, Amsterdam, The Netherlands, June 2003. i ERA-EDTA Registry Dept.
More informationThe number of patients waiting on the pancreas transplant list fell by 7% during the year, to 252 at 31 March 2015
6 Pancreas Activity Pancreas Activity Key messages The number of patients waiting on the pancreas transplant list fell by 7% during the year, to 252 at 31 March 2015 The number of pancreas donors after
More informationThe number of patients waiting on the pancreas transplant list fell by 1% during the year, to 224 at 31 March 2017
6 Pancreas Activity Pancreas Activity Key messages The number of patients waiting on the pancreas transplant list fell by 1% during the year, to 224 at 31 March 2017 The number of pancreas donors after
More informationUnited Kingdom Transplant Activity UK Transplant. Every statisticisaperson.
United Kingdom Transplant Activity 2001 UK Transplant Every statisticisaperson. Cover photograph: Caroline and John Fowler s daughter Aimee, now aged two, shared a donated liver in the first operation
More informationTransplantation in Australia and New Zealand
Transplantation in Australia and New Zealand Matthew D. Jose MBBS (Adel), FRACP, FASN, PhD (Monash), AFRACMA Professor of Medicine, UTAS Renal Physician, Royal Hobart Hospital Overview CKD in Australia
More informationThe number of patients registered on the kidney transplant list this year fell by 7% from 5686 to 5275
5 Kidney Activity Kidney Activity Key messages The number of patients registered on the kidney transplant list this year fell by 7% from 5686 to 5275 The number of deceased kidney donors increased by 7%
More informationThe number of patients registered on the kidney transplant list this year fell by 4% from 5,233 to 5,033
5 Kidney Activity Kidney Activity Key messages The number of patients registered on the kidney transplant list this year fell by 4% from 5,233 to 5,033 The number of deceased kidney donors increased by
More informationChapter 6: Transplantation
Chapter 6: Transplantation Introduction During calendar year 2012, 17,305 kidney transplants, including kidney-alone and kidney plus at least one additional organ, were performed in the United States.
More informationThe Irish Renal Transplant Registry: recipient demographics and outcomes / K.A. Abraham... [et al.]
The Irish Renal Transplant Registry: recipient demographics and outcomes / K.A. Abraham... [et al.] Item type Authors Rights Presentation Abraham, K A Beaumont Hospital Downloaded 10-Jul-2018 23:39:57
More informationINTERIM REPORT ON KIDNEY TRANSPLANTATION
INTERIM REPORT ON KIDNEY TRANSPLANTATION 5 YEAR REPORT (1 OCTOBER 2011 30 SEPTEMBER 2016) PUBLISHED MARCH 2017 PRODUCED IN COLLABORATION WITH NHS ENGLAND Contents 1 Executive Summary... 1 2 Introduction...
More informationDeceased donation data in the UK. Paul Murphy National Clinical Lead for Organ Donation United Kingdom
Deceased donation data in the UK Paul Murphy National Clinical Lead for Organ Donation United Kingdom Deceased donation data in the UK And the story behind it Paul Murphy National Clinical Lead for Organ
More informationKidney Transplantation in the Elderly. Kristian Heldal, MD, PhD Telemark Hospital Trust, Skien, Norway and University of Oslo
Kidney Transplantation in the Elderly Kristian Heldal, MD, PhD Telemark Hospital Trust, Skien, Norway and University of Oslo Agenda Background: Age and chronic kidney disease End stage kidney disease:
More informationThe number of patients on the active liver transplant list at 31 March 2017 was 530, a fall of 8% from 2016
8 Liver Activity Liver Activity Key messages The number of patients on the active liver transplant list at 31 March 2017 was 530, a fall of 8% from 2016 The number of liver donors after brain death increased
More informationANNUAL REPORT The Norwegian Renal Registry. (Norsk Nefrologiregister)
ANNUAL REPORT 21 The Norwegian Renal Registry (Norsk Nefrologiregister) This report will also be available on: http://152.94.12.23/nyreforening/uremiregisteret/esdr.html Correspondence to: Overlege dr.med
More informationIncidence of new patients starting RRT
SECTION A INCIDENCE A1 Incidence of new patients starting RRT A1.1 Incidence of new patients starting RRT 196-213 3 25 2 Number of 15 patients 1 5 367 425 749 119 169 2319 Year starting RRT 2799 2924 2635
More informationChapter 12. End Stage Kidney Disease in Indigenous Peoples of Australia and Aotearoa/New Zealand. ANZDATA Registry 39th Annual Report
Chapter 12 End Stage Kidney Disease in Indigenous Peoples of and Aotearoa/ 216 ANZDATA Registry 39th Annual Report Data to 31-Dec-215 Introduction In this chapter, the rates and practice patterns for end-stage
More informationAustralia & New Zealand Pancreas. Transplant Registry Report
Australia & New Zealand Pancreas Transplant Registry Report 1984-2009 This report is a compilation of data provided by the three current Pancreas transplant units in Australia and New Zealand: Auckland
More informationCHAPTER 12 END-STAGE KIDNEY DISEASE AMONG INDIGENOUS PEOPLES OF AUSTRALIA AND NEW ZEALAND. Stephen McDonald. Matthew Jose. Kylie Hurst INDIGENOUS 12-1
ANZDATA Registry 213 Report INDIGENOUS END-STAGE KIDNEY DISEASE AMONG INDIGENOUS PEOPLES OF AUSTRALIA AND NEW ZEALAND CHAPTER 12 Stephen McDonald Matthew Jose Kylie Hurst 213 Annual Report - 36th Edition
More informationManchester Royal Infirmary Renal & Pancreas Transplant Unit / 2011 Activity Annual Report
Manchester Royal Infirmary Renal & Pancreas Transplant Unit 21 / 211 Activity Annual Report Vicki Bowman Renal Transplant Audit & Data Manager Dr Susan Martin Consultant Clinical Scientist / Transplantation
More informationCHAPTER 12 END-STAGE KIDNEY DISEASE AMONG INDIGENOUS PEOPLES OF AUSTRALIA AND NEW ZEALAND. Matthew Jose Stephen McDonald Leonie Excell
CHAPTER 12 END-STAGE KIDNEY DISEASE AMONG PEOPLES OF AUSTRALIA AND NEW ZEALAND Matthew Jose Stephen McDonald Leonie Excell INTRODUCTION Rates of end-stage kidney disease among the Peoples of and are substantially
More informationSummary of Results for Laypersons
What was the Study Called? Summary of Results for Laypersons A Multicenter, Four Arm, Randomized, Open Label Clinical Study Investigating Optimized Dosing in a Prograf -/Advagraf -Based Immunosuppressive
More informationEnd Stage Kidney Disease Among Indigenous Peoples of Australia and New Zealand
Chapter 12 End Stage Kidney Disease Among Indigenous Peoples of and New Zealand 216 ANZDATA Registry 39th Annual Report Data to 31-Dec-215 Introduction In this chapter, rates of end-stage kidney disease
More informationOverview of drug-induced deaths in Europe - What does the data tell us?
Overview of drug-induced deaths in Europe - What does the data tell us? João Matias, Isabelle Giraudon, Julián Vicente EMCDDA expert group on the key-indicator Drug-related deaths and mortality among drug
More informationKidney Transplant Outcomes In Elderly Patients. Simin Goral MD University of Pennsylvania Medical Center Philadelphia, Pennsylvania
Kidney Transplant Outcomes In Elderly Patients Simin Goral MD University of Pennsylvania Medical Center Philadelphia, Pennsylvania Case Discussion 70 year old Asian male, neuropsychiatrist, works full
More informationWeekly Influenza Surveillance Report. Week 11
Weekly Influenza Surveillance Report Week 11 Report produced: 22/03/2001 Influenza activity in Ireland For the week ending the 18/03/01, week 11, influenza activity has increased. Sentinel general practices
More informationJames E. Cooper, M.D. Assistant Professor, University of Colorado at Denver Division of Renal Disease and Hypertension, Kidney and PancreasTransplant
James E. Cooper, M.D. Assistant Professor, University of Colorado at Denver Division of Renal Disease and Hypertension, Kidney and PancreasTransplant Program Has no real or apparent conflicts of interest
More informationProf. Dr. Gabor Ternak
Prof. Dr. Gabor Ternak Noninfectious diseases can't be passed from one person to another. Instead, these types of diseases are caused by factors such as the environment, genetics and lifestyle. The term
More informationPredictors of cardiac allograft vasculopathy in pediatric heart transplant recipients
Pediatr Transplantation 2013: 17: 436 440 2013 John Wiley & Sons A/S. Pediatric Transplantation DOI: 10.1111/petr.12095 Predictors of cardiac allograft vasculopathy in pediatric heart transplant recipients
More informationLong-term prognosis of BK virus-associated nephropathy in kidney transplant recipients
Original Article Kidney Res Clin Pract 37:167-173, 2018(2) pissn: 2211-9132 eissn: 2211-9140 https://doi.org/10.23876/j.krcp.2018.37.2.167 KIDNEY RESEARCH AND CLINICAL PRACTICE Long-term prognosis of BK
More informationFinnish Registry for Kidney Diseases Report 2001
Finnish Registry for Kidney Diseases Report 2001 Contents Finnish Registry for Kidney Diseases 2001...ii Board of the Finnish Registry for Kidney Diseases...iii The Finnish population and its distribution
More informationFor more information about how to cite these materials visit
Author(s): Silas P. Norman, M.D., 2009 License: Unless otherwise noted, this material is made available under the terms of the Creative Commons Attribution Noncommercial Share Alike 3.0 License: http://creativecommons.org/licenses/by-nc-sa/3.0/
More informationManchester Royal Infirmary Renal & Pancreas Transplant Unit / 2012 Activity Annual Report
Manchester Royal Infirmary Renal & Pancreas Transplant Unit 211 / 212 Activity Annual Report Vicki Bowman Renal Transplant Audit & Data Manager Dr Susan Martin Consultant Clinical Scientist / Transplantation
More informationSecular Trends in Cardiovascular Disease in Kidney Transplant Recipients: 1994 to 2009
Western University Scholarship@Western Electronic Thesis and Dissertation Repository June 2015 Secular Trends in Cardiovascular Disease in Kidney Transplant Recipients: 1994 to 2009 Ngan Lam The University
More informationExtract from Cancer survival in Europe by country and age: results of EUROCARE-5 a population-based study
EUROCARE-5 on-line database Data and methods Extract from Cancer survival in Europe 1999 2007 by country and age: results of EUROCARE-5 a population-based study De Angelis R, Sant M, Coleman MP, Francisci
More informationAccess and Outcomes Among Minority Transplant Patients, , with a Focus on Determinants of Kidney Graft Survival
American Journal of Transplantation 2010; 10 (Part 2): 1090 1107 Wiley Periodicals Inc. Special Feature No claim to original US government works Journal compilation C 2010 The American Society of Transplantation
More informationKidney Transplant Outcomes for Prolonged Cold Ischemic Times in the Context of Kidney Paired Donation
Kidney Transplant Outcomes for Prolonged Cold Ischemic Times in the Context of Kidney Paired Donation by Yayuk Joffres Thesis Submitted in Partial Fulfillment of the Requirements for the Degree of Master
More informationANNUAL REPORT The Norwegian Renal Registry. (Norsk Nyreregister)
ANNUAL REPORT 2016 The Norwegian Renal Registry (Norsk Nyreregister) This report will also be available on: http://www.nephro.no/registry.html Registry Chairperson: Anna V. Reisæter (areisate@ous-hf.no)
More informationSELECTED ABSTRACTS. All (n) % 3-year GS 88% 82% 86% 85% 88% 80% % 3-year DC-GS 95% 87% 94% 89% 96% 80%
SELECTED ABSTRACTS The following are summaries of selected posters presented at the American Transplant Congress on May 5 9, 2007, in San Humar A, Gillingham KJ, Payne WD, et al. Review of >1000 kidney
More informationCHAPTER 14. Renal Transplantation
15th Report of the Malaysian RENAL TRANSPLANTATION CHAPTER 14 Renal Transplantation Editor: Dr. Goh Bak Leong Expert Panel: : Dato Dr. Dato Zaki Dr. Morad Zaik Morad Mohd (Chair) Zaher (Chair) Dr. Goh
More informationCHAPTER 5. Paediatric Renal Replacement Therapy
24th Report of the CHAPTER 5 Paediatric Renal Replacement Therapy Lee Ming Lee Lim Yam Ngo Lynster Liaw Chiew Tung Susan Pee Yap Yok Chin Wan Jazilah Wan Ismail 24th Report of the SECTION A: RRT PROVISION
More informationTRENDS IN RENAL REPLACEMENT THERAPY IN BOSNIA AND HERZEGOVINA
& TRENDS IN RENAL REPLACEMENT THERAPY IN BOSNIA AND HERZEGOVINA 2002-2008 Halima Resić* 1, Enisa Mešić 2 1 Clinic for Hemodialysis, University of Sarajevo Clinics Centre, Bolnička 25, 71000 Sarajevo, Bosnia
More informationKidney and Pancreas Transplantation in the United States,
American Journal of Transplantation 2006; 6 (Part 2): 1153 1169 Blackwell Munksgaard No claim to original US government works Journal compilation C 2006 The American Society of Transplantation and the
More informationAustralia & New Zealand Pancreas. Transplant Registry Report
Australia & New Zealand Pancreas Transplant Registry Report 1984-2007 This report is a compilation of data provided by the five current Pancreas transplant units in Australia and New Zealand: Auckland
More informationEpidemiology of kidney diseases in children
Epidemiology of kidney diseases in children Dr Lesley Rees Gt Ormond St Hospital for Children, London, UK September 2015 Definition of Epidemiology The patterns, causes, and effects of health and diseases
More informationCHAPTER 5 RENAL TRANSPLANTATION. Editor: Dr Goh Bak Leong
CHAPTER 5 RENAL TRANSPLANTATION Editor: Dr Goh Bak Leong Expert Panel: Dr Goh Bak Leong (Chair) Dato Dr Zaki Morad Mohd Zaher Dato Dr (Mr) Rohan Malek Dr Fan Kin Sing Dr Lily Mushahar Dr Lim Soo Kun Dr
More informationDiabetes Mellitus GUIDELINES UNGRADED SUGGESTIONS FOR CLINICAL CARE IMPLEMENTATION AND AUDIT BACKGROUND
Diabetes Mellitus Date written: November 2011 Author: Scott Campbell GUIDELINES a. We recommend that diabetes should not on its own preclude a patient from being considered for kidney transplantation (1D).
More informationAustralia & New Zealand Pancreas. Transplant Registry Report Inquiries or comments should be directed to the secretariat at:
Australia & New Zealand Pancreas Transplant Registry Report 1984-2013 This report is a compilation of data provided by the four current Pancreas transplant units in Australia and New Zealand: Auckland
More informationUnited States Renal Data System (USRDS) International Data Collection Form
United States Renal Data System (USRDS) International Data Collection Form This form is designed to solicit information on the population of End-Stage Renal Disease (ESRD) patients in your country who
More informationReport Finnish Registry for Kidney Diseases. Number of patients at end of year y y. 5 9 y. 0 4 y
Finnish Registry for Kidney Diseases Number of patients at end of year 14 13 12 11 1 9 8 7 6 5 4 3 2 1-9 -95 - -5-1 15 19 y 1 14 y 5 9 y 4 y Finnish Registry for Kidney Diseases Contents Finnish Registry
More informationTransplant Activity in the UK
Transplant Activity in the UK 2006-2007 This document has been produced by the Statistics and Audit Directorate. UK Transplant August 2007 Cover pictures: Members of Glamorgan County cricket team help
More informationCHAPTER 5 RENAL TRANSPLANTATION. Editor: Dr Rosnawati Yahya
CHAPTER 5 Editor: Dr Rosnawati Yahya Expert Panels: Dr Rosnawati Yahya Dr Ng Kok Peng Dr Suryati Binti Yakaob Dr Mohd Zaimi Abd Wahab Dr Yee Seow Ying Dr Wong Hin Seng Contents 5. Stock and Flow of Renal
More information31 countries (117 registries, 20 national) Increased coverage in countries with regional registries 50% European population Overall >20 million
31 countries (117 registries, 20 national) Increased coverage in countries with regional registries 50% European population Overall >20 million cancer cases Adult patients (age 15+) 45 major cancer sites
More informationTRANSPLANT ACTIVITY IN THE UK
Activity Report 2010/11 TRANSPLANT ACTIVITY IN THE UK www.nhsbt.nhs.uk PREFACE This report has been produced by Statistics and Clinical Audit, NHS Blood and Transplant. All figures quoted in this report
More informationTransplant First: Addressing inequality in access to Kidney Transplantation in the West Midlands
Project Mandate Transplant First: Addressing inequality in access to Kidney Transplantation in the West Midlands West Midlands Cardiovascular Strategic Clinical Network Project Mandate Transplant First:
More informationCHAPTER 5 RENAL TRANSPLANTATION. Editor: Dr Goh Bak Leong
CHAPTER 5 RENAL TRANSPLANTATION Editor: Dr Goh Bak Leong Expert Panel: Dr Goh Bak Leong (Chair) Dato Dr (Mr) Rohan Malek Dr Wong Hin Seng Dr Fan Kin Sing Dr Rosnawati Yahya Dr S Prasad Menon Dr Tan Si
More informationKidney transplantation in the elderly the Norwegian experience
Nephrol Dial Transplant (2008) 23: 1026 1031 doi: 10.1093/ndt/gfm719 Advance Access publication 13 December 2007 Original Article Kidney transplantation in the elderly the Norwegian experience Kristian
More informationWESTERN EUROPE PREVALENCE AND INCIDENCE OF PERIPHERAL ARTERY DISEASE AND CRITICAL LIMB ISCHEMIA 2017
WESTERN EUROPE PREVALENCE AND INCIDENCE OF PERIPHERAL ARTERY DISEASE AND CRITICAL LIMB ISCHEMIA 2017 Mary L. Yost 404-520-6652 , LLC 23 Ridge Rd. Beaufort, SC 20097 Copyright Pending 2017 All rights reserved,
More informationQQuickly take me up into the bright child of your mind. E.E. CUMMINGS, The Enormous Room
QQuickly take me up into the bright child of your mind. E.E. CUMMINGS, The Enormous Room msix PEDIATrIC ESrD 18 ž 21 ATLAS OF ESRD IN THE UNITED STATES Incident rates of ESRD in children have risen two
More informationUSRDS UNITED STATES RENAL DATA SYSTEM
USRDS UNITED STATES RENAL DATA SYSTEM Chapter 8: Pediatric ESRD 1,462 children in the United States began end-stage renal disease (ESRD) care in 2013. 9,921 children were being treated for ESRD on December
More informationSimultaneous Pancreas Kidney Transplantation:
Simultaneous Pancreas Kidney Transplantation: What is the added advantage, and for whom? Alexander Wiseman, M.D. Associate Professor, Division of Renal Diseases and Hypertension Medical Director, Kidney
More informationChapter 5 PAEDIATRIC RENAL REPLACEMENT THERAPY. Lee Ming Lee Lim Yam Ngo Lynster Liaw Susan Pee Wan Jazilah Wan Ismail Yap Yok Chin
Chapter 5 PAEDIATRIC RENAL REPLACEMENT THERAPY Lee Ming Lee Lim Yam Ngo Lynster Liaw Susan Pee Wan Jazilah Wan Ismail Yap Yok Chin SECTION A: RRT PROVISION FOR PAEDIATRIC PATIENTS This chapter presents
More informationTransplant Nephrology Update: Focus on Outcomes and Increasing Access to Transplantation
Transplant Nephrology Update: Focus on Outcomes and Increasing Access to Transplantation Titte R Srinivas, MD, FAST Medical Director, Kidney and Pancreas Transplant Programs Objectives: Describe trends
More informationRenal Transplantation: Allocation challenges and changes. Renal Transplantation. The Numbers 1/13/2014
Renal Transplantation: Allocation challenges and changes Mark R. Wakefield, M.D., F.A.C.S. Associate Professor of Surgery/Urology Director Renal Transplantation Renal Transplantation Objectives: Understand
More informationIncidence of Rejection in Renal Transplant Surgery in the LVHN Population Leading to Graft Failure: 6 Year Review
Incidence of Rejection in Renal Transplant Surgery in the LVHN Population Leading to Graft Failure: 6 Year Review Jessica Ludolph 1 Lynsey Biondi, MD 1,2 and Michael Moritz, MD 1,2 1 Department of Surgery,
More informationOPTN/UNOS-Thoracic Organ Transplantation Committee: Proposed Modifications to Adult Heart Allocation
OPTN/UNOS-Thoracic Organ Transplantation Committee: Proposed Modifications to Adult Heart Allocation What problems is the proposal attempting to solve? Each zone = 500 mile radius Heart and Lung Allocation
More informationSummary of Results for Laypersons
What was the Study Called? Summary of Results for Laypersons A Multicenter, Three Arm, Randomized, Open Label Clinical Study to Compare Renal Function in Liver Transplant Recipients Receiving an Immunosuppressive
More informationThe FIND-CKD Study Background Study design (Results)
The FIND-CKD Study Background Study design (Results) The FIND-CKD Study An open-label, multicentre, randomized, 3 arm study comparing the 12-month efficacy and safety of Ferric carboxymaltose (FCM, Ferinject
More informationChapter 8: ESRD Among Children, Adolescents, and Young Adults
Chapter 8: ESRD Among Children, Adolescents, and Young Adults The number of children beginning end-stage renal disease (ESRD) care decreased by 6% in 2014, totaling 1,398 (Figure 8.1.a). 9,721 children
More informationChapter 7. Australian Waiting List. ANZDATA Registry 39th Annual Report. Data to 31-Dec-2015
Chapter 7 Australian Waiting List 216 ANZDATA Registry 39th Annual Report Data to 31-Dec-215 Stock and Flow The waiting list data reported here are derived from the Australian National Organ Matching System
More informationANNUAL REPORT The Norwegian Renal Registry. (Norsk Nefrologiregister)
Vedlegg 1 ANNUAL REPORT 25 The Norwegian Renal Registry (Norsk Nefrologiregister) This report will also be available on: http://www.nephro.no/registry.html Correspondence to: Overlege dr.med Torbjørn Leivestad
More informationPARTICULARS, SCHEDULE 2 THE SERVICES, A SERVICE SPECIFICATION. A03/S(HSS)/a Pancreas transplantation service (Adult)
A03/S(HSS)/a NHS STANDARD CONTRACT FOR PANCREAS TRANSPLANTATION SERVICE (ADULT) PARTICULARS, SCHEDULE 2 THE SERVICES, A SERVICE SPECIFICATION Service Specification No. Service Commissioner Lead Provider
More informationJ Am Soc Nephrol 14: , 2003
J Am Soc Nephrol 14: 208 213, 2003 Kidney Allograft and Patient Survival in Type I Diabetic Recipients of Cadaveric Kidney Alone Versus Simultaneous Pancreas/Kidney Transplants: A Multivariate Analysis
More informationThe New Kidney Allocation System: What You Need to Know. Anup Patel, MD Clinical Director Renal and Pancreas Transplant Division Barnabas Health
The New Kidney Allocation System: What You Need to Know Anup Patel, MD Clinical Director Renal and Pancreas Transplant Division Barnabas Health ~6% of patients die each year on the deceased donor waiting
More information2015 Children's Mercy Hospitals and Clinics. All Rights Reserved.
Growth van Stralen KJ, et al., Kidney Int, 2014 Blood Pressure Management van Stralen KJ, et al., Kidney Int, 2014 Sodium Losses on PD Infants might need higher UF rate per BSA as compared to adults to
More informationCHAPTER 5 RENAL TRANSPLANTATION
CHAPTER 5 RENAL TRANSPLANTATION Editor: Dr. Goh Bak Leong Expert Panel: Dato Dr. Zaki Morad b Mohd Zaher (Chair) Dr. Goh Bak Leong (Co-Chair) Dr. Fan Kin Sing Dr. Lily Mushahar Mr. Rohan Malek Dr. S. Prasad
More informationChronic renal histological changes at implantation and subsequent deceased donor kidney transplant outcomes: a single-centre analysis
Chronic renal histological changes at implantation and subsequent deceased donor kidney transplant outcomes: a single-centre analysis Benedict Phillips 1, Kerem Atalar 1, Hannah Wilkinson 1, Nicos Kessaris
More informationPaired Donation. Andrew Bradley Rachel Johnson Joanne Allen Susan V Fuggle. Cambridge University NHS Hospitals NHS Foundation trust
Paired Donation Andrew Bradley Rachel Johnson Joanne Allen Susan V Fuggle Cambridge University NHS Hospitals NHS Foundation trust Showing a preference 1860 John Calcott Horsley UK Living Donor kidney transplant
More informationDonor Quality Assessment
Donor Quality Assessment Francesc Moreso, MD, PhD Renal Transplant Unit Hospital Universitari Vall d Hebron Barcelona. Spain 4/9/2017 Donor Quality Assessment 1 What is the problem? Across all age ranges,
More informationLiving Donor Paired Exchange (LDPE)
Living Donor Paired Exchange (LDPE) Why do we need Living Donation? 3,796 patients waiting for an organ transplant 2,679 (71%) waiting for a kidney transplant 249 people died while waiting for an organ
More informationLiterature Review: Transplantation July 2010-June 2011
Literature Review: Transplantation July 2010-June 2011 James Cooper, MD Assistant Professor, Kidney and Pancreas Transplant Program, Renal Division, UC Denver Kidney Transplant Top 10 List: July Kidney
More informationChapter 7: ESRD among Children, Adolescents, and Young Adults
Chapter 7: ESRD among Children, Adolescents, and Young Adults The one-year end-stage renal disease (ESRD) patient mortality among the 0-4 year age group has declined approximately 41.6% over the past decade.
More informationMycophenolate mofetil in low-risk renal transplantation in patients receiving no cyclosporine: a single-centre experience
840 O.A. Raheem et al. Nephrol Dial Transplant (2012) 27: 840 844 doi: 10.1093/ndt/gfr263 Advance Access publication 28 May 2011 Mycophenolate mofetil in low-risk renal transplantation in patients receiving
More informationU.S. changes in Kidney Allocation
U.S. changes in Kidney Allocation Match kidneys with longest survival to patients with longest survival No parallel matching for kidneys with lower survival potential Decrease discard of kidneys with lower
More informationWINTER SEASON 2016/17 MORTALITY SUMMARY REPORT FROM THE EUROMOMO NETWORK
WINTER SEASON 2016/17 MORTALITY SUMMARY REPORT FROM THE EUROMOMO NETWORK Pooled analysis of all-cause and influenza-attributable mortality from 21 European countries participating in the EuroMOMO network
More informationLIVE KIDNEY DONOR RISK PREDICTION ; NEW PARADIGM, NEW CALCULATORS PEDRAM AHMADPOOR MD
LIVE KIDNEY DONOR RISK PREDICTION ; NEW PARADIGM, NEW CALCULATORS PEDRAM AHMADPOOR MD Outline: PART 1 : Update on safety of nephrectomy for living donor candidate PART 2 : Latest guideline recommendation
More informationSteroid Minimization: Great Idea or Silly Move?
Steroid Minimization: Great Idea or Silly Move? Disclosures I have financial relationship(s) within the last 12 months relevant to my presentation with: Astellas Grants ** Bristol Myers Squibb Grants,
More informationRENINE Annual Report 2015
RENINE Annual Report 2015 T. Hoekstra, M.H. Hemmelder, F.J. van Ittersum In cooperation with the sectie Registratie (Registration division) of the Nederlandse Federatie voor Nefrologie (NfN; Dutch federation
More informationHome Hemodialysis or Transplantation of the Treatment of Choice for Elderly?
Home Hemodialysis or Transplantation of the Treatment of Choice for Elderly? Miklos Z Molnar, MD, PhD, FEBTM, FERA, FASN Associate Professor of Medicine Division of Nephrology, Department of Medicine University
More informationORIGINAL ARTICLE. Eric F. Martin, 1 Jonathan Huang, 3 Qun Xiang, 2 John P. Klein, 2 Jasmohan Bajaj, 4 and Kia Saeian 1
LIVER TRANSPLANTATION 18:914 929, 2012 ORIGINAL ARTICLE Recipient Survival and Graft Survival are Not Diminished by Simultaneous Liver-Kidney Transplantation: An Analysis of the United Network for Organ
More informationNAPRTCS Annual Transplant Report
North American Pediatric Renal Trials and Collaborative Studies NAPRTCS 2014 Annual Transplant Report This is a privileged communication not for publication. TABLE OF CONTENTS PAGE II TRANSPLANTATION Section
More informationVaccinations pre- and posttransplant. Burkhard Tönshoff, MD, PhD University Children s Hospital Heidelberg, Germany
Vaccinations pre- and posttransplant Burkhard Tönshoff, MD, PhD University Children s Hospital Heidelberg, Germany Background Increased risk of both common and opportunistic infections after Tx due to
More informationCardiovascular Risk Reduction in Kidney Transplant Recipients
Cardiovascular Risk Reduction in Kidney Transplant Recipients Rainer Oberbauer R.O. AUG 2010 CV Mortality in ESRD compared to the general population R.O.2/32 Modified from Foley et al. AJKD 32 (suppl3):
More informationCHAPTER 4 METHOD AND LOCATION OF DIALYSIS. Nancy Briggs Kylie Hurst Stephen McDonald Annual Report 35th Edition
CHAPTER 4 METHOD AND LOCATION OF DIALYSIS Nancy Briggs Kylie Hurst Stephen McDonald 212 Annual Report 35th Edition METHOD AND LOCATION OF DIALYSIS ANZDATA Registry 212 Report AUSTRALIA Figure 4.1 Aust
More information